IMO,
Growth in revenues and earnings can no longer be measured using 2011, 2012 as a base as so many here still wish to discuss in regards to mbe's great growth story.
With expansion into many o/s markets as well as many o/s partnerships, the market expects to see growth in revenues and profits on a qtr to qtr basis going forward.
Why is so hard for management to release figures for the first 5 months of 2015 as they were only to happy to release many trading updates last year and early this year...
Come on Thorpey release some good news and stop this downward avalanche
DYOR
- Forums
- ASX - By Stock
- IMS
- Festive Buying Season
Festive Buying Season, page-12
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online